Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomer M Mark

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Clinical Advances in Hematology & Oncology : H&O|January 10, 2018
Incorporating monoclonal antibodies into the management of multiple myelomaTomer M Mark
Oncotargets and Therapy|June 28, 2014
Potential role of daratumumab in the treatment of multiple myelomaYulian Khagi, Tomer M Mark
Leukemia & Lymphoma|January 5, 2016
Clonal plasma cells keep strange companyTomer M Mark, Karen Pekle
Acta Haematologica|October 28, 2015
It's Time to Take Clarithromycin Seriously in Multiple MyelomaTomer M Mark, Morton Coleman
Future Oncology (London, England)|July 11, 2013
Pomalidomide in the treatment of relapsed multiple myelomaPeter A Forsberg, Tomer M Mark
Current Hematologic Malignancy Reports|August 16, 2015
Novel Induction Regimens in Multiple MyelomaKarie D Runcie, Tomer M Mark
Current Oncology (Toronto, Ont.)|July 25, 2022
Clinical Management of Triple-Class Refractory Multiple Myeloma: A Review of Current Strategies and Emerging TherapiesMargaret E Stalker, Tomer M Mark
Current Hematologic Malignancy Reports|August 27, 2013
Management of double-refractory multiple myelomaJason P Meadows, Tomer M Mark
Leukemia Research|April 3, 2014
Preclinical and clinical results with pomalidomide in the treatment of relapsed/refractory multiple myelomaTomer M Mark, Morton Coleman, Ruben Niesvizky
Clinical Lymphoma, Myeloma & Leukemia|July 24, 2017
Monoclonal Antibodies in Multiple Myeloma: A New Wave of the FutureDaniel W Sherbenou, Tomer M Mark, Peter Forsberg
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Clinical Advances in Hematology & Oncology : H&O|January 10, 2018
Incorporating monoclonal antibodies into the management of multiple myelomaTomer M Mark
Oncotargets and Therapy|June 28, 2014
Potential role of daratumumab in the treatment of multiple myelomaYulian Khagi, Tomer M Mark
Leukemia & Lymphoma|January 5, 2016
Clonal plasma cells keep strange companyTomer M Mark, Karen Pekle
Acta Haematologica|October 28, 2015
It's Time to Take Clarithromycin Seriously in Multiple MyelomaTomer M Mark, Morton Coleman
Future Oncology (London, England)|July 11, 2013
Pomalidomide in the treatment of relapsed multiple myelomaPeter A Forsberg, Tomer M Mark
Current Hematologic Malignancy Reports|August 16, 2015
Novel Induction Regimens in Multiple MyelomaKarie D Runcie, Tomer M Mark
Current Oncology (Toronto, Ont.)|July 25, 2022
Clinical Management of Triple-Class Refractory Multiple Myeloma: A Review of Current Strategies and Emerging TherapiesMargaret E Stalker, Tomer M Mark
Current Hematologic Malignancy Reports|August 27, 2013
Management of double-refractory multiple myelomaJason P Meadows, Tomer M Mark
Leukemia Research|April 3, 2014
Preclinical and clinical results with pomalidomide in the treatment of relapsed/refractory multiple myelomaTomer M Mark, Morton Coleman, Ruben Niesvizky
Clinical Lymphoma, Myeloma & Leukemia|July 24, 2017
Monoclonal Antibodies in Multiple Myeloma: A New Wave of the FutureDaniel W Sherbenou, Tomer M Mark, Peter Forsberg
Pageof 5